<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://www.pennstemtimes.com/article/910439198-abivax-announces-repurchase-of-royalty-certificates-and-pricing-of-45m-38-5m-offering-of-american-depositary-shares</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T06:00:00+00:00</news:publication_date>
        <news:title>Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910439216-kinetic-deploys-fiber-optic-network-for-a-more-reliable-digital-future</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T05:21:08+00:00</news:publication_date>
        <news:title>Kinetic Deploys Fiber-Optic Network for a More Reliable Digital Future</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YTk3YjM5OTktMmNkNC00OWFjLWE1OGYtZTJiZWYxMmQ3NjIyLTUwMDE2MjEyNC0yMDI2LTA1LTA1LWVu/tiny/Kinetic.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910429701-santhera-ver-ffentlicht-einladung-zur-ordentlichen-generalversammlung</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T05:00:00+00:00</news:publication_date>
        <news:title>Santhera veröffentlicht Einladung zur ordentlichen Generalversammlung</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910429709-santhera-publishes-agenda-for-its-annual-general-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T05:00:00+00:00</news:publication_date>
        <news:title>Santhera Publishes Agenda for its Annual General Meeting </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/logo-jpg.JPG</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910410583-gauth-launches-live-tutor-in-vietnam-expanding-access-to-personalized-ai-learning-support</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T03:00:00+00:00</news:publication_date>
        <news:title>Gauth Launches Live Tutor in Vietnam, Expanding Access to Personalized AI Learning Support</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e59917c4-2978-4e18-b33e-f4d600b4a967/medium/gauth-live-tutor.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910410585-gauth-ra-m-t-t-nh-n-ng-live-tutor-t-i-vi-t-nam-m-r-ng-kh-n-ng-ti-p-c-n-h-tr-h-c-t-p-ai-c-nh-n-h-a</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T03:00:00+00:00</news:publication_date>
        <news:title>Gauth Ra Mắt Tính Năng Live Tutor Tại Việt Nam, Mở Rộng Khả Năng Tiếp Cận Hỗ Trợ Học Tập AI Cá Nhân Hóa</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/6fee188f-4308-4720-ab4f-43ee512b0463/image3.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910253848-logistics-plus-founder-jim-berlin-transitions-to-chairman-names-yuriy-ostapyak-as-ceo</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:00:00+00:00</news:publication_date>
        <news:title>Logistics Plus Founder Jim Berlin Transitions to Chairman; Names Yuriy Ostapyak as CEO</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24846872-yuriy-ostapyak-ceo-of-logistic-2009x1897.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910361222-axiant-launches-with-innovative-process-first-methodology-to-address-automation-failures</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T22:42:00+00:00</news:publication_date>
        <news:title>Axiant Launches with Innovative Process-First Methodology to Address Automation Failures</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3251527/axiant-logo.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910342560-nanobiotix-announces-protocol-amendment-to-ongoing-global-phase-3-head-and-neck-cancer-study</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T21:29:27+00:00</news:publication_date>
        <news:title>Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910342587-nanobiotix-annonce-un-amendement-du-protocole-de-l-tude-mondiale-de-phase-3-sur-le-cancer-de-la-t-te-et-du-cou</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T21:29:27+00:00</news:publication_date>
        <news:title>NANOBIOTIX ANNONCE UN AMENDEMENT DU PROTOCOLE DE L’ÉTUDE MONDIALE DE PHASE 3 SUR LE CANCER DE LA TÊTE ET DU COU</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910342532-edgesource-corporation-acquires-lyteworx-automation-systems-deepening-its-defense-and-intelligence-mission-capabilities</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T21:28:35+00:00</news:publication_date>
        <news:title>Edgesource Corporation Acquires Lyteworx Automation Systems, Deepening Its Defense and Intelligence Mission Capabilities</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ba7fdda5-6ced-4314-801e-44f9e00da542/small/edgesource-logo-pr-1200-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910342447-jiade-limited-announces-pricing-of-up-to-12-0-million-registered-direct-offering</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T21:10:00+00:00</news:publication_date>
        <news:title>JIADE LIMITED Announces Pricing of up to $12.0 Million Registered Direct Offering</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/66c132ba-862c-42c5-92fc-aab67a82bf74/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910342497-enviri-corporation-announces-results-of-the-special-meeting-of-stockholders</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T21:09:19+00:00</news:publication_date>
        <news:title>Enviri Corporation Announces Results of the Special Meeting of Stockholders</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/11e6100c-87a3-4f26-b5ee-f12b242e43ca/small/enviri-integrityline-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910342356-new-publication-demonstrates-tlx250-px-zircaix-potential-in-diagnosing-kidney-cancers-beyond-ccrcc</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T21:00:00+00:00</news:publication_date>
        <news:title>New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910333422-tango-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:31:00+00:00</news:publication_date>
        <news:title>Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d6e37a27-2e33-43bb-ae05-bfb0dedbf190/small/tango-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910333352-teva-to-present-at-the-bofa-securities-health-care-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>Teva to Present at the BofA Securities Health Care Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/c2001734-949b-4cc2-8021-b4b64eda1f13/small/teva-rgb-jpeg-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910333368-vor-bio-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/dde67700-b1b4-40c4-b930-13bd71804762/small/vor-wordmark-rgb-fullcolor-070920-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910333377-cellectis-to-report-first-quarter-financial-results-on-may-11-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>Cellectis to Report First Quarter Financial Results on May 11, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910333384-cellectis-publiera-ses-r-sultats-financiers-du-premier-trimestre-le-11-mai-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>Cellectis publiera ses résultats financiers du premier trimestre le 11 mai 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910333396-crispr-therapeutics-provides-business-update-and-reports-first-quarter-2026-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5dac7d0d-131d-4047-bab7-db8e0719bf58/small/crispr-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910333425-microvast-schedules-first-quarter-earnings-call</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>Microvast Schedules First Quarter Earnings Call</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/df776795-0f3f-47ee-8207-63d8c61b98bb/small/microvast-tag-bluewhite-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910333429-opus-genetics-announces-fda-acceptance-of-opgx-lca5-into-rare-disease-evidence-principles-rdep-program</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/468baef1-3b2d-4353-a17e-cb41b45ee6ef/small/opus-rgb-r-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910333432-eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/db07cafa-b35c-4d61-a1a1-d330caf67ad2/small/eton-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910333456-bioage-to-host-r-d-day-focused-on-nlrp3-inhibition-on-may-8-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>BioAge to Host R&amp;D Day Focused on NLRP3 Inhibition on May 8, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d6df9eb5-87f7-4e2e-b503-8a7d8651428e/small/bioage-dark-logo-white-bg-500x500-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910333491-cvrx-announces-first-patient-enrollment-in-benefit-hf-a-landmark-heart-failure-trial-evaluating-barostim-in-significantly-expanded-population</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/04c4feba-7841-4ac8-8ca5-6c03be383a0e/small/cvrx-outsmart-the-heart-logo-rgb-blue-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910333399-anaptys-to-participate-at-the-h-c-wainwright-2nd-annual-royalty-company-virtual-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:15:00+00:00</news:publication_date>
        <news:title>Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/eb223f66-e7e0-4e0a-94e7-a3f7a06b13ab/small/anaptys-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910333489-kuvi-integrates-with-kucoin-broker-pro-to-advance-agentic-finance-adoption</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:15:00+00:00</news:publication_date>
        <news:title>Kuvi Integrates with KuCoin Broker Pro to Advance Agentic Finance Adoption</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/eff106d2-82fe-40b8-a438-742d86074e01/small/555-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910324529-3-e-network-technology-signs-1-3m-convertible-note-agreement-with-institutional-investor</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:10:00+00:00</news:publication_date>
        <news:title>3 E Network Technology Signs 1.3M Convertible Note Agreement with Institutional Investor</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8f4e21c2-5e2c-4ce6-88ee-66c06500e891/small/22222-2026-01-14-183954-150-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910324540-kyntra-bio-to-report-first-quarter-2026-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Kyntra Bio to Report First Quarter 2026 Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9105c1e9-d9e3-4b68-9fc8-261fed7db250/small/kyntra-bio-r-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910324550-tactile-systems-technology-inc-reports-first-quarter-2026-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Tactile Systems Technology, Inc. Reports First Quarter 2026 Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7ecb6926-a715-4305-979c-a80795dbab83/small/tactile-medical-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910324583-rumble-announces-timing-of-first-quarter-2026-earnings-release-and-conference-call</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Rumble Announces Timing of First Quarter 2026 Earnings Release and Conference Call</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e41a1c60-94cb-441c-8c8e-c8202cad5bce/small/image1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910324622-clip-money-inc-announces-amendment-of-unsecured-convertible-notes</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Clip Money Inc. Announces Amendment of Unsecured Convertible Notes</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/80569958-6412-49bc-802d-e98810b40181/small/logo-800-300dpi-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910324625-everquote-announces-first-quarter-2026-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>EverQuote Announces First Quarter 2026 Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/86005bfc-f760-4c2f-9bfc-d896152a9bea/small/everquote-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910324647-silvaco-announces-participation-at-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Silvaco Announces Participation at Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/86c898ba-7d91-45b3-9db0-edb7315ddaba/small/silvaco-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910324650-capricor-therapeutics-to-report-first-quarter-2026-financial-results-and-provide-recent-corporate-update-on-may-12</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/16ce4387-5b8f-447c-96b8-7c453633f9bf/small/getimage-48-768x274-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910324654-lexicon-pharmaceuticals-announces-100-million-loan-facility-with-hercules-capital</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/afcf3b59-ca71-40ed-9226-a0901bf4d13b/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910324720-aktis-oncology-initiates-phase-1b-clinical-trial-for-aky-2519-a-b7-h3-miniprotein-radioconjugate-in-metastatic-castration-resistant-prostate-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/490bbb9a-2b27-4a72-8d7a-333387326d8b/small/aktis-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910324766-oric-pharmaceuticals-reports-first-quarter-2026-financial-results-and-operational-updates</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>ORIC® Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Updates</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/acbc0ad2-7a44-4ee7-b729-ab92d57ffafb/small/oric-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910324758-ocugen-announces-private-offering-of-115-million-of-convertible-senior-notes</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:01:51+00:00</news:publication_date>
        <news:title>Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910324495-praxis-precision-medicines-to-report-first-quarter-2026-financial-results-on-thursday-may-7-2026-and-participate-in-upcoming-investor-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:01:00+00:00</news:publication_date>
        <news:title>Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910324509-fibrobiologics-reports-preclinical-data-showing-fibroblast-spheroids-may-actively-reprogram-the-burn-wound-environment-to-drive-healing-and-reduce</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:01:00+00:00</news:publication_date>
        <news:title>FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/720fe0fe-52b4-4ccc-a5ad-95d4288f1df2/small/fibrobiologics-logo-2022-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910324510-biodesix-announces-first-quarter-2026-results-and-highlights</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:01:00+00:00</news:publication_date>
        <news:title>Biodesix Announces First Quarter 2026 Results and Highlights</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b2fd8e3c-ff04-47d9-938d-93c9c961ccc3/small/bdsx-logo-1200x240-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910324629-hemab-therapeutics-announces-closing-of-upsized-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:01:00+00:00</news:publication_date>
        <news:title>Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/M2UyM2ExNWYtYTJjYi00M2RhLTkwZGEtNjZlYTUyMzI4NTI4LTEzMjE4MjEtMjAyNi0wNS0wNC1lbg==/tiny/Hemab-Therapeutics-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910324596-cytokinetics-to-announce-topline-results-from-acacia-hcm-the-pivotal-phase-3-clinical-trial-of-aficamten-in-patients-with-non-obstructive</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:00:00+00:00</news:publication_date>
        <news:title>Cytokinetics to Announce Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy, on May 5, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910324602-visionary-holdings-inc-announces-receipt-of-nasdaq-delisting-determination-letter-related-to-delinquent-listing-fees</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:00:00+00:00</news:publication_date>
        <news:title>Visionary Holdings Inc. Announces Receipt of Nasdaq Delisting Determination Letter Related to Delinquent Listing Fees</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/Mzc5NzU4NDctOGU1ZC00Y2JjLWE1YjEtMjkxMmYzYjM3M2Q3LTEzMTczMjYtMjAyNi0wNS0wNC1lbg==/tiny/Visionary-Holdings-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910324663-crn-recognizes-11-employees-at-climb-channel-solutions-on-the-2026-women-of-the-channel-list-and-names-climb-s-chief-marketing-officer-as-one-of-the</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T19:29:34+00:00</news:publication_date>
        <news:title>CRN Recognizes 11 Employees at Climb Channel Solutions on the 2026 Women of the Channel List and Names Climb’s Chief Marketing Officer as one of the 2026 Women of the Channel Power 100</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c7f62397-551b-4c5f-ac67-cd3baeeb84e4/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910315198-roadzen-announces-pricing-of-8-million-registered-direct-offering-of-ordinary-shares</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T19:27:19+00:00</news:publication_date>
        <news:title>Roadzen Announces Pricing of $8 Million Registered Direct Offering of Ordinary Shares</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5101ee32-4aaf-4552-aa26-c4ed796caf72/small/roadzen-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910315145-liabilityscore-announces-new-platform-to-bring-credit-score-logic-to-contract-risk-built-for-small-businesses-not-lawyers</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T19:20:00+00:00</news:publication_date>
        <news:title>LiabilityScore Announces New Platform to Bring Credit-Score Logic to Contract Risk — Built for Small Businesses, Not Lawyers</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3240312/Commercial-Lease-Score.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910306646-sana-commerce-appoints-brian-plackis-cheng-as-ceo</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T18:20:25+00:00</news:publication_date>
        <news:title>Sana Commerce Appoints Brian Plackis Cheng as CEO</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/ec9f9caa-d98f-47e3-acc7-b19eaab978ae/small/sana-logotype-red-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910298991-michael-haske-to-become-isolved-ceo-as-company-embarks-on-next-phase-of-ai-led-growth</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T18:00:00+00:00</news:publication_date>
        <news:title>Michael Haske to Become isolved CEO as Company Embarks on Next Phase of AI-Led Growth</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c7803669-a575-4be5-a22a-b9982b790c1c/small/isolved-logo-color-pos-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910298983-amazon-one-medical-glp-1-program-evaluated-how-the-new-program-works-what-it-costs-and-what-cash-pay-patients-should-know-first</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T17:51:04+00:00</news:publication_date>
        <news:title>Amazon One Medical GLP-1 Program Evaluated: How the New Program Works, What It Costs, and What Cash-Pay Patients Should Know First</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ee6fb8bf-1ad4-4b37-8ad6-34f3692f808e/medium/direct-meds.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910291456-admaxxer-surpasses-5-000-active-brands-and-1-2-billion-in-tracked-gmv-reinforcing-its-position-as-a-leading-dtc-analytics-and-ai-ad-operations</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T17:05:00+00:00</news:publication_date>
        <news:title>Admaxxer Surpasses 5,000 Active Brands and $1.2 Billion in Tracked GMV, Reinforcing Its Position as a Leading DTC Analytics and AI Ad Operations Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3248977/Admaxxer-Surpasses-5%2C000-Active-Brands-and-%241.2-Billion-in-Tracked-GMV%2C-Reinforcing-Its-Position-as-a-Leading-DTC-Analytics-and-AI-Ad-Operations-Platform-Press.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910291473-eascra-biotech-welcomes-dr-anne-yau-as-life-science-research-scientist</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T17:04:04+00:00</news:publication_date>
        <news:title>Eascra Biotech Welcomes Dr. Anne Yau as Life Science Research Scientist</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1eda41c1-8c5d-43f0-9198-b0a1570f47e6/medium/dr-anne-yau.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910278459-deepinfra-closes-107m-series-b-to-power-production-scale-ai-inference</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T16:00:00+00:00</news:publication_date>
        <news:title>DeepInfra Closes $107M Series B to Power Production-Scale AI Inference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f36602ae-b2cf-4f29-be62-c811818f6e32/small/deepinfra-logo-horizontal-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910278468-samba-tv-bolsters-technical-leadership-with-promotion-of-jaya-aswani-to-cto-and-appointment-of-ramzi-nasr-as-vp-of-engineering</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T16:00:00+00:00</news:publication_date>
        <news:title>Samba TV bolsters technical leadership with promotion of Jaya Aswani to CTO and appointment of Ramzi Nasr as VP of Engineering</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/25a74fa7-09fe-4ed7-8189-1587683af145/small/samba-tv-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910278471-carahsoft-recognized-in-2025-broadcom-partner-awards</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T16:00:00+00:00</news:publication_date>
        <news:title>Carahsoft Recognized in 2025 Broadcom Partner Awards</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ee2f2b02-4089-4a15-93fa-0956daf4ad82/small/carahsoft-blue-logo-web-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910278515-asentum-announces-ase-token-presale-ahead-of-post-quantum-mainnet-release</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T16:00:00+00:00</news:publication_date>
        <news:title>Asentum Announces $ASE Token Presale Ahead of Post-quantum Mainnet Release</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ff6e601c-253e-46a5-aeb1-de722f4fdcd5/small/screenshot-2026-04-30-104146-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910278486-microcloud-hologram-inc-efficient-deterministic-quantum-state-preparation-algorithm-based-on-decision-diagrams</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T15:40:00+00:00</news:publication_date>
        <news:title>MicroCloud Hologram Inc. Efficient Deterministic Quantum State Preparation Algorithm Based on Decision Diagrams</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/OWYyYTNlYjctOWMzYi00ZmU4LWEyMTktOTQwOWU0MGM5Y2M1LTEzMTA4OTctMjAyNi0wNS0wNC1lbg==/tiny/MicroCloud-Hologram-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910278494-focus-school-software-celebrates-20-years-as-a-leading-national-provider-of-k-12-technology-solutions</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T15:34:49+00:00</news:publication_date>
        <news:title>Focus School Software Celebrates 20 Years as a Leading National Provider of K-12 Technology Solutions</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/559730d4-2aa4-418f-81fa-507e7f90d91b/small/focus-logo-1200x630-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910272579-warmysender-reaches-15-000-users-reinforcing-position-as-top-instantly-alternative</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T15:15:00+00:00</news:publication_date>
        <news:title>WarmySender Reaches 15,000 Users, Reinforcing Position as Top Instantly Alternative</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3248932/WarmySender-Reaches-15%2C000-Users%2C-Reinforcing-Position-as-Top-Instantly-Alternative-Press.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910272589-flyguys-launches-reality-behind-the-flight-a-new-podcast-exploring-the-world-of-reality-data-capture</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T15:11:34+00:00</news:publication_date>
        <news:title>FlyGuys Launches “Reality: Behind the Flight,” A New Podcast Exploring the World of Reality Data Capture</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MDIxMjMxODItNjljMi00ZmM3LTgyNDMtMzVlZmE5MWI0ODQxLTUwMDE2MjAxNy0yMDI2LTA1LTA0LWVu/tiny/FlyGuys-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910272515-intuitive-ai-achieves-aws-data-and-analytics-competency-as-enterprises-reassess-the-foundations-of-ai</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T15:00:00+00:00</news:publication_date>
        <news:title>Intuitive.ai achieves AWS Data and Analytics Competency as Enterprises Reassess the Foundations of AI</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3fc27a9a-561c-455c-b3a6-6a83ba8090b8/small/intuitive-logo-secondary-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910272541-sophos-celebrates-22-leaders-named-to-2026-crn-women-of-the-channel-list</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:56:39+00:00</news:publication_date>
        <news:title>Sophos Celebrates 22 Leaders Named to 2026 CRN Women of the Channel List</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/35db908a-b7b8-4ce0-b920-69875da346ba/small/sophos-1200x628-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910266621-jama-software-launches-model-context-protocol-mcp-server</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:45:00+00:00</news:publication_date>
        <news:title>Jama Software Launches Model Context Protocol (MCP) Server</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0f19efa9-cf4d-43a0-9f83-4d48de067aec/small/jama-software-logo.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910266571-flexera-channel-leaders-spotlighted-across-the-crn-2026-women-of-the-channel-list</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:30:00+00:00</news:publication_date>
        <news:title>Flexera Channel Leaders Spotlighted Across the CRN® 2026 Women of the Channel List</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/691aa193-5f37-4e50-8fec-38e34f7a5e43/small/97e88b00-acec-4133-812f-8213dba8f99b-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910262632-mmi-s-symani-surgical-system-treats-first-alzheimer-s-patient-in-groundbreaking-remind-study</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:10:00+00:00</news:publication_date>
        <news:title>MMI’s Symani Surgical System Treats First Alzheimer’s Patient in Groundbreaking REMIND Study</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e9325bed-8fcb-4abf-b66e-6f076014b0fb/small/mmi-logo-stacked-tagline-positive-rgb1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910262667-owlting-group-nasdaq-owls-launches-owlpay-agent-wallet-targeting-the-emerging-multi-trillion-dollar-agentic-commerce-economy</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:07:50+00:00</news:publication_date>
        <news:title>OwlTing Group (NASDAQ: OWLS) Launches OwlPay Agent Wallet, Targeting the Emerging Multi-Trillion-Dollar Agentic Commerce Economy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5a79481c-55d1-4e33-9f88-950aa88aeec5/medium/owlting-built-the-wallet-the-agentic-economy-needs-self-cust.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910262611-research-on-new-class-of-treatments-for-ovarian-cancer-receives-725-000-in-funding-from-ovarian-cancer-canada-to-become-clinical-trial-ready</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:00:00+00:00</news:publication_date>
        <news:title>Research on new class of treatments for ovarian cancer receives $725,000 in funding from Ovarian Cancer Canada to become “clinical trial-ready”</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YWY2NGZiYWEtODcyZC00Y2I5LThkZGEtYmM5ZjlkYzFkNDMzLTEzMTI5NjUtMjAyNi0wNS0wNC1lbg==/tiny/Ovarian-Cancer-Canada.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910262624-inqi-launches-ai-native-property-intelligence-platform-with-new-editor-and-expanded-iq-apps</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:00:00+00:00</news:publication_date>
        <news:title>InQI Launches AI-Native Property Intelligence Platform with New Editor and Expanded IQ Apps</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3244005/inqi_image_2.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910262626-spring-allergies-hit-lungs-hard-doctor-of-pharmacy-explains-what-actually-helps</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:00:00+00:00</news:publication_date>
        <news:title>Spring Allergies Hit Lungs Hard: Doctor of Pharmacy Explains What Actually Helps</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/13a92186-d8d0-4494-9e0a-5fc1d2e363ee/small/betterbrand-logo-new-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910258304-talkdesk-announces-new-integration-to-deliver-unified-healthcare-experience-and-outcomes-analytics</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:32:15+00:00</news:publication_date>
        <news:title>Talkdesk announces new integration to deliver unified healthcare experience and outcomes analytics</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b806fec8-0de9-496b-9ddc-7775b20acf14/small/talkdesk-logo-png.PNG</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910258255-coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:30:00+00:00</news:publication_date>
        <news:title>Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/07437af0-8ae3-48cf-952b-18bc6b99ca7c/small/coherus-onc-logo-rgb-150-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910258274-intouch-insight-study-finds-mobile-ordering-success-hinges-on-reliability-not-speed</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:30:00+00:00</news:publication_date>
        <news:title>Intouch Insight Study Finds Mobile Ordering Success Hinges on Reliability, Not Speed</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MDhhNGZhN2MtZWVhZi00MWIwLTkxZDEtNmUyMjQ1ODIxMzM0LTUwMDE1NjYxNy0yMDI2LTA1LTA0LWVu/tiny/Intouch-Insight.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910258286-alpha-tau-announces-100-local-disease-control-rate-and-favorable-safety-profile-observed-in-alpha-dart-pancreatic-cancer-trials-presented-at-ddw</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:17:21+00:00</news:publication_date>
        <news:title>Alpha Tau Announces 100% Local Disease Control Rate and Favorable Safety Profile Observed in Alpha DaRT® Pancreatic Cancer Trials Presented at DDW 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910258285-alternative-ballistics-corporation-otcqb-albc-to-host-corporate-update-call-on-may-7-2026-at-8-30-am-et</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:15:00+00:00</news:publication_date>
        <news:title>Alternative Ballistics Corporation (OTCQB: ALBC) to Host Corporate Update Call on May 7, 2026 at 8:30 AM ET</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6f3eddb5-8d1a-420e-b07f-3e21f440c666/small/albc-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910252863-prismatic-launches-skills-for-claude-code-to-help-developers-ship-integrations-faster</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:05:00+00:00</news:publication_date>
        <news:title>Prismatic Launches Skills for Claude Code to Help Developers Ship Integrations Faster</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3ffa5f28-f782-4562-9961-b68fe61d97c2/medium/prismatic-launches-skills-for-claude-code.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910253033-greece-launches-world-s-first-national-wildfire-satellite-system-with-ororatech</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:04:00+00:00</news:publication_date>
        <news:title>Greece Launches World’s First National Wildfire Satellite System with OroraTech</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f405d4dd-2633-4e23-8086-bbaa6bf83b25/medium/ororatech-s-hellenic-fire-system.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910253114-aura-biosciences-announces-pricing-of-260-million-public-offering-of-common-stock-and-pre-funded-warrants</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:03:06+00:00</news:publication_date>
        <news:title>Aura Biosciences Announces Pricing of $260 Million Public Offering of Common Stock and Pre-funded Warrants</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910252843-operant-ai-launches-endpoint-protector-securing-shadow-ai-coding-agents-and-mcp-across-the-enterprise</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:00:00+00:00</news:publication_date>
        <news:title>Operant AI Launches Endpoint Protector: Securing Shadow AI, Coding Agents, and MCP Across the Enterprise</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cf992a83-aa53-4fbe-8acd-1dbc5d0de200/small/operant-black-logo-master-png-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910252851-asus-releases-2026-future-of-small-business-report</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:00:00+00:00</news:publication_date>
        <news:title>ASUS Releases 2026 Future of Small Business Report</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3239907/Future-of-SMB-Report.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910252862-carnosyn-brands-expands-tribsyn-applications-across-beverage-dairy-and-medical-nutrition</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:00:00+00:00</news:publication_date>
        <news:title>CarnoSyn® Brands Expands TriBsyn® Applications Across Beverage, Dairy, and Medical Nutrition</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4b40dd5b-0137-41f8-83de-422e4b4f3196/small/nai-full-logo-green2-0-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910252869-oncolytics-biotech-reports-durable-responses-in-second-line-ras-mutant-mss-colorectal-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:00:00+00:00</news:publication_date>
        <news:title>Oncolytics Biotech® Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f0121259-b2be-4290-90a3-0d2c3b243aed/small/oncolytics-biotech-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910252951-turtle-beach-corporation-restructures-credit-facilities-to-enhance-capital-return-flexibility</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:00:00+00:00</news:publication_date>
        <news:title>Turtle Beach Corporation Restructures Credit Facilities to Enhance Capital Return Flexibility</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f8a9689c-6753-486d-b902-84d519018cbe/small/turtlebeachcorp-logo-stacked-blk-28-11-2023-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910252971-fate-therapeutics-announces-three-presentations-at-the-2026-asgct-annual-meeting-highlighting-off-the-shelf-car-t-cell-therapy-pipeline-for-cancer-and</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:00:00+00:00</news:publication_date>
        <news:title>Fate Therapeutics Announces Three Presentations at the 2026 ASGCT Annual Meeting Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910253027-quantum-x-labs-files-u-s-patent-application-for-high-precision-quantum-atomic-clock-for-potential-use-in-the-aerospace-defense-industries</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:52:00+00:00</news:publication_date>
        <news:title>Quantum X Labs Files U.S. Patent Application for High Precision Quantum Atomic Clock for Potential Use in the Aerospace &amp; Defense Industries</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a0abc50a-ff3e-420e-9e21-807bbc6417cd/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910253043-gyre-therapeutics-completes-acquisition-of-cullgen-to-create-u-s-and-china-based-fully-integrated-biopharmaceutical-company</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:47:47+00:00</news:publication_date>
        <news:title>Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/24951768-57e9-4d7a-b969-f00258b17136/small/gyre-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910253010-polyrizon-announces-u-s-patent-expansion-for-its-intranasal-drug-delivery-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:45:00+00:00</news:publication_date>
        <news:title>Polyrizon Announces U.S. Patent Expansion for Its Intranasal Drug Delivery Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YWIxMzIzNDgtN2UwNy00NTAyLThjZDMtZWMwNGFjZTdmNWJhLTUwMDEyOTIyMy0yMDI2LTA1LTA0LWVu/tiny/Polyrizon-Ltd-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910252891-aitx-to-present-at-the-ld-micro-invitational-xvi</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:40:00+00:00</news:publication_date>
        <news:title>AITX to Present at the LD Micro Invitational XVI</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/882a78f6-94c4-4a5c-a750-564a6dea2bb5/small/aitx-logo-1920x1080-2-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910247553-mapi-pharma-explores-u-s-aseptic-manufacturing-facility-to-support-growing-demand-for-aseptic-and-long-acting-generic-and-innovative-injectables</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Mapi Pharma Explores U.S. Aseptic Manufacturing Facility to Support Growing Demand for Aseptic and Long-Acting Generic and innovative Injectables</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a15e698a-0f26-4d44-bf6a-78b7ae34d25d/small/mapi-pharma-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910247597-abeona-therapeutics-announces-date-of-first-quarter-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Abeona Therapeutics® Announces Date of First Quarter Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f11f9f14-9744-4666-aef3-9771488c41bd/small/thumb-1740-12-silhouette-vertical-full-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910247608-satellogic-expands-global-sales-force-with-senior-defense-and-intelligence-industry-veterans</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Satellogic Expands Global Sales Force with Senior Defense and Intelligence Industry Veterans</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d2d0c386-2a99-4434-aa48-fc69a11ff8a7/small/satellogic-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910247610-fibrobiologics-announces-release-of-cywc628-drug-product-for-phase-1-2-diabetic-foot-ulcer-clinical-trial</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/720fe0fe-52b4-4ccc-a5ad-95d4288f1df2/small/fibrobiologics-logo-2022-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910247630-fortress-biotech-to-participate-in-the-h-c-wainwright-2nd-annual-royalty-company-virtual-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d82bf2ce-81b7-4989-9e6b-08e6bb6e1f95/small/fortressbio1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910247641-service-robotics-growth-accelerates-as-global-demand-fuels-strategic-expansion</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Service Robotics Growth Accelerates as Global Demand Fuels Strategic Expansion</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/45ff7033-6ad2-41ba-bbd1-912eb2907b3e/small/ainewswire-002-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910247668-liquidia-corporation-to-report-first-quarter-2026-financial-results-on-may-11-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f7659070-cc55-4e68-ae70-33013e7df72c/small/liquidia-new-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910247674-newgen-provides-update-on-fiscal-year-2025-results-and-strategic-progress</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>NewGen Provides Update on Fiscal Year 2025 Results and Strategic Progress</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZWQwY2VjNmQtYTdlZi00YTUxLTg3NmItMmI3OWVkMTQ5MGQ4LTEyOTcwMTEtMjAyNi0wNS0wNC1lbg==/tiny/NewGenIvf-Limited.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910247689-axe-compute-inc-nasdaq-agpu-ceo-chris-miglino-to-appear-on-schwab-network-may-4-and-cheddar-may-6</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Axe Compute Inc. (NASDAQ: AGPU) CEO Chris Miglino to Appear on Schwab Network May 4 and Cheddar May 6</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0722059f-4d31-435e-974f-ff669a2cb2e4/small/axe-compute.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910242598-candel-therapeutics-to-host-investor-conference-call-following-presentation-of-extended-data-from-phase-3-trial-of-aglatimagene-besadenovec-in</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:05:00+00:00</news:publication_date>
        <news:title>Candel Therapeutics to Host Investor Conference Call Following Presentation of Extended Data from Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910242367-proqr-announces-annual-general-meeting-of-shareholders-to-be-held-june-2-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/f5ae7794-bff7-44dc-8709-0e9c3a9eac77/small/logo-proqr-150x150-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910242370-dr-falk-pharma-and-renexxion-announce-positive-results-on-naronapride-in-gastroparesis-from-the-global-phase-2b-move-it-trial</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/7cf77d4a-25b5-4471-a282-0334907cbfbd/small/falk-logo-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910242372-dr-falk-pharma-and-renexxion-announce-positive-results-on-naronapride-in-gastroparesis-from-the-global-phase-2b-move-it-trial</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/540f0a78-db35-42ad-9e90-7b81e8ff3ad6/small/renirl-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910242373-cptx-to-present-preclinical-proof-of-principle-of-its-dna-based-in-vivo-car-t-platform-at-asgct-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>CPTx to present preclinical proof-of-principle of its DNA-based in vivo CAR T platform at ASGCT Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/b3ec9ca7-8866-466a-9d91-09342002e341/small/cptx-logo-high-res-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910242419-evaxion-to-announce-business-update-and-first-quarter-2026-financial-results-on-may-7-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910242435-recludix-pharma-announces-upcoming-oral-presentations-on-preclinical-data-for-oral-stat6-inhibitor-rex-8756-and-topical-stat-1-3-inhibitors-at-the</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Recludix Pharma Announces Upcoming Oral Presentations on Preclinical Data for Oral STAT6 Inhibitor REX-8756 and Topical STAT 1/3 Inhibitors at the Society for Investigative Dermatology (SID) Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NDM5ZGUzYTItNGI0Zi00N2Y3LWE3Y2QtZmViNDYyN2I1ZWRjLTEyMzYyMjItMjAyNi0wNS0wNC1lbg==/tiny/Recludix-Pharma-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910242438-rhythm-pharmaceuticals-announces-new-data-presentations-in-acquired-hypothalamic-obesity-at-pediatric-endocrine-society</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910242442-spur-therapeutics-presents-clinical-insights-on-bone-disease-impact-of-flt201-in-adults-with-gaucher-disease-type-1</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Spur Therapeutics Presents Clinical Insights on Bone Disease Impact of FLT201 in Adults with Gaucher Disease Type 1</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/195ccecc-f977-4fb5-ba01-43af7ec47589/small/spur-therapeutics-black-wopacity-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910242445-zoom-recognizes-the-rise-of-ai-powered-businesses-of-one-with-inaugural-solopreneur-50</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Zoom Recognizes the Rise of AI-Powered Businesses of One with Inaugural Solopreneur 50</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1a5e6f52-9a8e-432b-84cc-7dfb0e6623e2/small/logo-zm-app-icon-container-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910242449-kyverna-therapeutics-appoints-nadia-dac-seasoned-commercial-leader-in-neurology-and-rare-disease-as-chief-commercial-officer</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c166e9f5-941a-48b0-be17-c24d54785784/small/kyverna-primary-full-2-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910242457-4dmt-to-participate-in-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>4DMT to Participate in Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910242470-valitor-presents-preclinical-data-demonstrating-superior-durability-with-six-month-treatment-protocol-of-vltr-559-to-treat-wet-amd</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Valitor Presents Preclinical Data Demonstrating Superior Durability with Six-month Treatment Protocol of VLTR-559 to Treat Wet AMD</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/58da3c80-c616-4358-9bbe-2936ace96649/small/valitor-sidebyside-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910242472-applied-digital-announces-300-million-senior-secured-bridge-facility</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Applied Digital Announces $300 Million Senior Secured Bridge Facility</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a09f7f80-1e66-44ed-b53a-6007ec7be92a/small/applied-digital-logo-horizontal-black-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910242494-tessell-appoints-matt-mcdonough-and-jeffrey-carter-to-executive-team-to-accelerate-enterprise-database-modernization</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Tessell Appoints Matt McDonough and Jeffrey Carter to Executive Team to Accelerate Enterprise Database Modernization</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/503f121a-0162-4ce3-84b3-ae5e04dc98e5/medium/jeff-carter-chief-strategy-officer.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910242516-kaltura-open-sources-suite-of-ai-agent-skills-enabling-any-ai-agent-to-build-intelligent-rich-media-digital-experiences</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Kaltura Open-Sources Suite of AI Agent Skills, Enabling Any AI Agent to Build Intelligent Rich-Media Digital Experiences  </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/584e487b-dd12-4a20-a5b1-c42f4579d369/small/kaltura-logo-vertical-colorsun-blacktext-small.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910242538-lifeward-announces-new-rewalk-data-presented-at-asia-2026-conference-demonstrating-a-comprehensive-longitudinal-safety-analysis-for-a-powered</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9343d7ac-5bc7-4a60-a2c9-a41bf7b5e007/small/lifeward-full-logo-rgb-for-web-01-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910242564-atsena-presents-positive-interim-six-month-results-from-part-b-of-phase-1-2-3-lighthouse-trial-evaluating-atsn-201-in-patients-with-x-linked</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Atsena Presents Positive Interim Six-Month Results from Part B of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/90d0bd84-4404-435c-9875-3473b4cc7172/small/atsena-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910242567-rocket-doctor-ai-reports-strong-2025-results-validating-physician-led-model-with-key-u-s-payer-contracts-and-ai-innovation</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Rocket Doctor AI Reports Strong 2025 Results, Validating Physician-Led Model with Key U.S. Payer Contracts and AI Innovation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/648c6dd6-c4c0-4ceb-9a78-26fecd4678a7/small/rocket-doctor-logo-250821-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910242574-after-successful-fda-meeting-clene-filing-accelerated-approval-nda-for-als</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e9de96a4-582e-4975-8e43-6f3e6259c075/small/clene-logo-2x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910242582-legend-biotech-expands-scientific-advisory-expertise-to-inform-future-growth</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d3a680c2-cab6-4eb2-9ed0-7be055f9e180/small/legend-logo-fullcolor-transparent-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910242595-swarmer-partners-with-rakuten-to-enter-japan-s-advanced-autonomy-market</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Swarmer Partners With Rakuten to Enter Japan&#39;s Advanced Autonomy Market</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/46b28796-9654-4d2b-89db-91de399ba76a/small/swarmer-logo-dark-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910242608-ruanyun-edai-technology-s-saudi-rhq-signs-mou-with-wadi-makkah-a-subsidiary-of-umm-al-qura-university</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Ruanyun Edai Technology’s Saudi RHQ Signs MOU with Wadi Makkah, A Subsidiary of Umm Al-Qura University</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0b7372f3-6354-4bba-acc5-bb10b1de4c3a/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910237832-macrogenics-and-sagard-healthcare-partners-enter-into-expanded-zynyz-royalty-purchase-agreement</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/72a7b58c-b7ca-4cd5-b2bb-185124351f1c/small/macrogenics-logo-transparent-background-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910237841-bridgebio-to-present-new-acoramidis-data-on-disease-progression-biomarkers-and-clinical-outcomes-at-esc-heart-failure-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910237849-kura-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ebf510d7-3727-4cc8-894f-6ce2d82b941a/small/kura-logo-for-globe-newswire-prs-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910237860-palvella-therapeutics-announces-first-patients-dosed-in-phase-2-lotu-trial-of-fast-track-designated-qtorin-rapamycin-for-clinically-significant</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>Palvella Therapeutics Announces First Patients Dosed in Phase 2 LOTU Trial of Fast Track-Designated QTORIN™ Rapamycin for Clinically Significant Angiokeratomas</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/83fd569b-5e6c-46ad-882a-6430f8ab755a/small/palvella-2025-logo-new-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910237878-inflarx-reports-favorable-reactive-metabolite-profile-for-izicopan-in-human-liver-microsomes</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e017df5c-9a9b-4f4f-9a94-6c2eeb0400bc/small/inflarx-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910237897-earthdaily-advancing-daily-global-measurement-of-planetary-change-with-six-satellites-launched</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>EarthDaily Advancing Daily Global Measurement of Planetary Change with Six Satellites Launched</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/63895f31-922c-451d-894e-110f2f640ad9/medium/earthdaily-satellite-deploys.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910237911-windward-bio-announces-165m-crossover-financing-to-advance-pipeline-of-long-acting-immunology-therapies-with-best-in-disease-potential</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>Windward Bio Announces $165M Crossover Financing to Advance Pipeline of Long-Acting Immunology Therapies With Best-in-Disease Potential</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/Nzk5NDkzNGQtNWZiNi00MGZkLTg2ZTAtYzViNDkwNTJjOTVmLTUwMDEzMTYxMS0yMDI2LTA1LTA0LWVu/tiny/Windward-Bio.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910237925-micropolis-robotics-unveils-new-next-generation-high-endurance-robot-at-the-make-it-in-the-emirates-2026-industry-exhibition</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:29:19+00:00</news:publication_date>
        <news:title>Micropolis Robotics Unveils New, Next-Generation, High-Endurance Robot at the Make it in the Emirates 2026 Industry Exhibition</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ffdb8f0a-5da0-4cdc-9a97-852140e69d8b/medium/m1-5.JPG</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910237843-cartesian-therapeutics-announces-new-employment-inducement-grants</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:05:00+00:00</news:publication_date>
        <news:title>Cartesian Therapeutics Announces New Employment Inducement Grants</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2bf78841-be30-4bb5-bfb5-0b5f383f3302/small/cartesian-logo-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910237845-nextcure-and-simcere-zaiming-initiate-dose-optimization-for-sim0505-cdh6-adc-in-gynecologic-cancers</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:05:00+00:00</news:publication_date>
        <news:title>NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancers</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910237870-kraig-biocraft-laboratories-launches-april-may-production-cycle-following-record-spider-silk-output</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:05:00+00:00</news:publication_date>
        <news:title>Kraig Biocraft Laboratories Launches April/May Production Cycle Following Record Spider Silk Output</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3cf5ab91-0822-460b-bb13-17447941c84a/small/kblb-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910233519-ardena-strengthens-executive-team-to-drive-its-next-phase-of-growth</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Ardena Strengthens Executive Team to Drive its Next Phase of Growth</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/eddef504-18ee-4f10-8442-9e61ef77e262/medium/ardena-appoints-cfo-and-cco.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910233520-indivior-announces-175-million-accelerated-share-repurchase</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Indivior Announces $175 Million Accelerated Share Repurchase</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/42de3285-90ea-4020-a3ad-25f71026b41a/small/indivior-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910233589-advanced-technology-recycling-atr-announces-that-they-are-now-offering-wholesale-electronics-to-the-general-public-through-their-online-auction-site</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Advanced Technology Recycling (ATR) Announces That They Are Now Offering Wholesale Electronics to the General Public Through Their Online Auction Site</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/437d4f24-24b9-4cd4-961b-ea5dd0ab80ce/small/atr-logo-with-registered-trademark-badge-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910233590-biocryst-announces-european-licensing-agreement-with-irish-affiliate-of-neopharmed-gentili-for-navenibart-in-hereditary-angioedema</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8b033909-1a3c-4811-b07b-fe03b12e00d2/small/biocryst-primarylogo-r-2c-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910233621-tenax-therapeutics-appoints-timothy-healey-mba-as-chief-commercial-officer</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d8c1d3b1-51a5-4835-a9e8-6d5bce14917e/small/tenax-logo-rgb-color-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910233629-krystal-biotech-announces-first-quarter-2026-financial-and-operating-results</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Krystal Biotech Announces First Quarter 2026 Financial and Operating Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/94ec1f39-c0eb-4e65-9d7e-250519ef03f4/small/krys-logo-nobackground-with-registered-symbol-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910233642-10-barrel-brewing-launches-clean-slate-and-salty-sips-expanding-rtd-line-with-functional-n-a-and-low-sugar-cocktails</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>10 Barrel Brewing Launches Clean Slate and Salty Sips, Expanding RTD Line with Functional N/A and Low-Sugar Cocktails</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5e71b27b-1cc8-4780-8689-8d8d6ae86236/medium/clean-slate-and-salty-sips.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910233645-seres-therapeutics-presents-preclinical-data-at-digestive-disease-week-ddw-2026-supporting-ser-603-a-next-generation-cultivated-live-biotherapeutic</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f8c3ad50-d1a3-457d-b0c7-8f9237db7f93/small/seres-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910233649-centrum-launches-newly-reformulated-adults-50-complete-multivitamin-with-clinically-shown-cognitive-benefits</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Centrum Launches Newly Reformulated Adults 50+ Complete Multivitamin with Clinically Shown Cognitive Benefits</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/395df94a-8079-4f58-9b54-df434e56ec33/medium/centrum-adults-50-complete-multivitamin.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910233653-centrum-lance-sa-multivitamine-compl-te-adultes-50-nouvellement-reformul-e-avec-des-bienfaits-cognitifs-d-montr-s-cliniquement</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Centrum lance sa multivitamine complète Adultes 50+ nouvellement reformulée avec des bienfaits cognitifs démontrés cliniquement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/abbbfaf3-e52b-413c-9ded-52f74cf50911/medium/centrum-multivitamine-complete-pour-adultes-50.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910233661-genyro-announces-new-paper-demonstrating-how-sidewinder-technology-democratizes-dna-construction-at-scale-and-facilitates-ai-driven-protein-design</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Genyro Announces New Paper Demonstrating How Sidewinder Technology Democratizes DNA Construction at Scale and Facilitates AI-Driven Protein Design</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/346f123b-cc5d-4de0-a31f-9c4f1315c070/medium/genyro-co-founders.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910233678-seer-announces-appointment-of-anthony-bazarko-as-chief-commercial-officer</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ecdddbc3-8a58-4cba-a4a1-33971e79339a/medium/anthony-bazarko.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910233683-istios-health-partners-with-care-id-to-expand-national-infectious-disease-clinical-research-network</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Istios Health Partners with CARE-ID to Expand National Infectious Disease Clinical Research Network</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MTI0OGVmYTMtNmZkNC00ODA4LWJlNzUtNTYxODJlODcxNDBmLTEzMTYxMjEtMjAyNi0wNS0wNC1lbg==/tiny/Istios-Health.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910233687-adma-biologics-announces-fda-approval-to-expand-the-label-for-asceniv-to-include-pediatric-immune-compromised-patients-two-years-of-age-and-older</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910233694-meet-sprysite-the-website-builder-and-marketing-platform-redefining-small-business-websites</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Meet SprySite: The Website Builder and Marketing Platform Redefining Small Business Websites</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3244560/sprypro.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910233575-descartes-sets-date-to-announce-first-quarter-fiscal-2027-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T10:45:00+00:00</news:publication_date>
        <news:title>Descartes Sets Date to Announce First Quarter Fiscal 2027 Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2fab20c0-6dcb-4891-840a-37d0d482f33a/small/descartes-systems-group-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910233704-cabaletta-bio-announces-pricing-of-150-million-underwritten-offering</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T10:35:54+00:00</news:publication_date>
        <news:title>Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/44175396-6bbb-435f-b037-54a4052160d4/small/cabaletta-bio-registered-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910224348-aura-biosciences-announces-proposed-public-offering-of-common-stock-and-pre-funded-warrants</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T10:03:00+00:00</news:publication_date>
        <news:title>Aura Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910224335-aura-biosciences-announces-ceo-transition-as-company-advances-phase-3-compass-trial-toward-enrollment-completion</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T10:01:00+00:00</news:publication_date>
        <news:title>Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910224345-scilex-holding-company-announces-its-board-of-directors-approved-may-26-2026-as-the-payment-date-of-the-previously-announced-dividend-of-dream-bowl</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T10:00:00+00:00</news:publication_date>
        <news:title>Scilex Holding Company Announces Its Board of Directors Approved May 26, 2026 as the Payment Date of the Previously Announced Dividend of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the…</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e2f985bf-0880-4d05-8838-90a69c888cf9/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910216010-what-is-the-best-internet-solution-for-business-travel-why-holafly-for-business-is-becoming-the-preferred-choice-for-global-companies</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T08:54:07+00:00</news:publication_date>
        <news:title>What is the best internet solution for business travel? Why Holafly for Business is becoming the preferred choice for global companies</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/ff9372ad-41f6-4acc-8266-5578d80cc425/medium/why-holafly-for-business-is-becoming-the-preferred-choice-fo.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910206820-virtune-ab-publ-virtune-hat-die-monatliche-neugewichtung-f-r-april-2026-des-virtune-crypto-altcoin-index-etps-durchgef-hrt</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T08:06:34+00:00</news:publication_date>
        <news:title>Virtune AB (Publ) („Virtune“) hat die monatliche Neugewichtung für April 2026 des Virtune Crypto Altcoin Index ETPs durchgeführt</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/da0bec69-79eb-4618-87fd-d96aa395aaed/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910206825-virtune-ab-publ-virtune-has-completed-the-monthly-rebalancing-for-april-2026-of-its-virtune-crypto-altcoin-index-etp</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T08:06:34+00:00</news:publication_date>
        <news:title>Virtune AB (Publ) (&quot;Virtune&quot;) has completed the monthly rebalancing for April 2026 of its Virtune Crypto Altcoin Index ETP</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/da0bec69-79eb-4618-87fd-d96aa395aaed/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910206829-virtune-ab-publ-virtune-har-genomf-rt-den-m-natliga-rebalanseringen-f-r-april-2026-av-virtune-crypto-altcoin-index-etp</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T08:06:34+00:00</news:publication_date>
        <news:title>Virtune AB (Publ) (&quot;Virtune&quot;) har genomfört den månatliga rebalanseringen för april 2026 av Virtune Crypto Altcoin Index ETP</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/da0bec69-79eb-4618-87fd-d96aa395aaed/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910188220-proper-hills-launches-ultra-slim-alloy-magnetic-power-bank-for-design-conscious-consumers</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T05:30:58+00:00</news:publication_date>
        <news:title>Proper Hills Launches Ultra-Slim Alloy Magnetic Power Bank for Design-Conscious Consumers</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/382df764-328b-4049-8389-ac0950f52367/medium/proper-hills-just-made-a-power-bank-thinner-than-a-pencil-th.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910177238-unbounded-vision-dreame-window-cleaning-robot-debuts-in-north-america-redefining-vertical-cleaning-with-precision-technology</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T04:17:56+00:00</news:publication_date>
        <news:title>Unbounded Vision: Dreame Window Cleaning Robot Debuts in North America, Redefining Vertical Cleaning with Precision Technology</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/d9c436d7-c9c5-46ff-8495-5a11d321f6a3/3-5.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910162333-lakefusion-raises-7-5m-seed-financing-to-redefine-master-data-management-mdm-natively-on-databricks</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T02:02:10+00:00</news:publication_date>
        <news:title>LakeFusion Raises $7.5M Seed Financing to Redefine Master Data Management (MDM) Natively on Databricks</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/78680f0e-2aae-4cb5-8bf0-8e3d8bb6b896/medium/lakefusion-raises-7-5m-seed-financing-to-redefine-master-dat.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910150844-novelty-nobility-taps-agc-biologics-to-further-develop-bispecific-drug-candidate</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T00:00:00+00:00</news:publication_date>
        <news:title>Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cecf4f80-22df-4bbf-b0a7-f50b9acf9495/medium/agc-biologics-and-novelty-nobility-representatives-meet.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910150881-agc</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T00:00:00+00:00</news:publication_date>
        <news:title>ノベルティ・ノビリティ、AGCバイオロジクスと提携し、二重特異性抗体候補薬の開発を推進</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NWUzMzQxMTYtZjcyYS00YjQ4LWE2ODYtY2ZiNWE0YTlmM2MzLTEzMTU5MjMtMjAyNi0wNS0wNC1qYQ==/tiny/AGC-Biologics-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910150885-novelty-nobility-agc-biologics</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T00:00:00+00:00</news:publication_date>
        <news:title>노벨티 노빌리티 (Novelty Nobility), 이중특이성 항체 개발 위해 AGC Biologics와 협력 확대</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NWUzMzQxMTYtZjcyYS00YjQ4LWE2ODYtY2ZiNWE0YTlmM2MzLTEzMTU5MjMtMjAyNi0wNS0wNC1rbw==/tiny/AGC-Biologics-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910145359-crypto-news-today-alphapepe-presale-ai-dex-hits-final-testing-whilst-bitcoin-price-prediction-points-to-120-000</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-03T23:30:00+00:00</news:publication_date>
        <news:title>Crypto News Today: AlphaPepe Presale AI DEX Hits Final Testing Whilst Bitcoin Price Prediction Points to $120,000</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2c8b0156-2a64-4138-b75f-f7aaa8bdfd49/medium/alphapepe.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910130237-neuro-salt-under-investigation-full-pink-salt-trick-consumer-report-reveals-shocking-hidden-risks</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-03T20:52:12+00:00</news:publication_date>
        <news:title>Neuro Salt Under Investigation: Full &quot;Pink Salt Trick&quot; Consumer Report Reveals Shocking Hidden Risks</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5b7201ce-5f4e-4a97-9fe8-95a77e66b2b7/medium/neuro-salt.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910111834-luma-glasses-unveiled-does-lumaglasses-smart-ai-glasses-really-works-read-luma-glasses-consumer-report</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-03T18:16:40+00:00</news:publication_date>
        <news:title>Luma Glasses Unveiled: Does LumaGlasses Smart AI Glasses Really Works? Read Luma Glasses Consumer Report! </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c2a2f020-e4e2-491b-aa89-89d3efaa0309/medium/luma-glasses.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910074985-russian-oil-asset-fund-launches-public-website-and-solana-token-information-hub-for-roaf</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-03T13:00:00+00:00</news:publication_date>
        <news:title>Russian Oil Asset Fund Launches Public Website and Solana Token Information Hub for $ROAF</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a1ac6677-6dcc-4559-8941-b2ce8d5537ad/small/555-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.pennstemtimes.com/article/910068316-bsstrategy-introduces-ai-powered-trading-workspace-for-strategy-development-and-portfolio-management</loc>
      <news:news>
        <news:publication>
          <news:name>Penn STEM Times</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-03T12:00:00+00:00</news:publication_date>
        <news:title>BsStrategy Introduces AI-Powered Trading Workspace for Strategy Development and Portfolio Management</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/29228b48-2078-4e24-8423-55e6f010abde/medium/bsstrategy-logo.png</image:loc>
        </image:image>
    </url>
</urlset>
